TrialPath
Recruiting

LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study

NCT05645510 · University of Alberta
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

About this study
Participants ill be scheduled for an in-person, telephone or computer video interview with the researcher(s). They will be asked about their experiences receiving targeted anti-cancer treatments. Then over the next 3 months, participants will be asked to think about how receiving these cancer treatments affects daily living and to create a 'metaphor'. Metaphors may be composed with any mix of visual, verbal, musical or other works participants feel expresses and brings their experiences to life.
Eligibility criteria
Inclusion Criteria: taking chronic targeted anti-cancer agents - Exclusion Criteria: \-
Study design
Enrollment target: 75 participants
Age groups: adult, older_adult
Timeline
Starts: 2022-11-24
Estimated completion: 2026-06-09
Last updated: 2026-05-11
Primary outcomes
  • Interview (3 months)
Sponsor
University of Alberta · other
With: Social Sciences and Humanities Research Council of Canada
Contacts & investigators
ContactEdith Pituskin, PhD · contact · pituskin@ualberta.ca · 7804328221
ContactMeredith Porter Hogg, MN · contact · lngeviti@ualberta.ca
All locations (1)
Edith PituskinRecruiting
Edmonton, Alberta, Canada
LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study · TrialPath